Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Main Capital in connection with its acquisition of Björn Lundén AB
Mandate

Vinge has advised Main Capital in connection with its acquisition of Björn Lundén AB

July 08, 2021 Employment and Benefits Intellectual Property M&A

Björn Lundén AB, founded in 1987, provides accounting and financial software solutions targeted at accounting firms and SMEs.

Björn Lundén serves over 30,000 companies in the Swedish market and has 120 employees. The company has developed a comprehensive portfolio of solutions and tools for administration, finance, accounting, tax, legal and personnel administration and in addition offers knowledge tools, books and courses in the aforementioned areas.

Vinge’s team consisted of Filip Öhrner, Henrik Borna, Daniel Daun, Lena Westberg, Ellinor Wargenbrant, Nando Basic, Jonathan Hörnblad (M&A), Emelie Svensäter Jerntorp, Karin Gynnerstedt (Employment), Lisa Bourghardt (IP) and Ellinore Boström Andersson.

Related

Vinge has advised Vimian Group AB in connection with its uplisting to Nasdaq Stockholm

Vinge has advised Vimian Group AB (publ) in connection with its list change from Nasdaq First North Growth Market to Nasdaq Stockholm’s main market, Large cap. The prospectus was published on 21 March 2025 and the trading on Nasdaq Stockholm commenced on 28 March 2025.
March 28, 2025

Vinge advises Tribune Therapeutics in conjunction with financing round

 Vinge advises Tribune Therapeutics, a Swedish biotechnology company focused on developing therapies for fibrotic diseases, in raising 23 MEUR. The financing round includes the previous investors HealthCap, Novo Holding and Innovestor, in addition to the new investors LifeArc Ventures, Industrifonden and Investinor.
March 26, 2025

Vinge advises Dignitana on the public offer from Paxman

 Paxman AB (publ) has announced a public offer to the shareholders of Dignitana AB. The total value of the offer is approximately SEK 153 million.
March 24, 2025